In a document published this Thursday, November 14, Health Insurance takes stock of the consumption of medicines by the French. In particular, the list of reimbursed medications most consumed in France is presented.
Doliprane and other broad leading analgesics
Unsurprisingly, it is Doliprane, currently at the heart of a political-economic battle, which is in the lead. But the surprise perhaps comes from the quantity consumed: 308.2 million boxes in 2023, sold to 36.1 million patients.
The second most purchased drug, which is also from the analgesic family, is Dafalgan, with 71.6 million boxes, sold to 6.8 million patients. Note that another painkiller, Efferalgan, is 5th in the ranking, with 23.9 million boxes sold to 2.6 million patients.
Levothyrox, 3e best-selling drug in France
The podium of the best-selling medically in France is completed by Levothyrox. In total, 31.6 million boxes of this drug, used to regulate thyroid troops and a modification of the formula of which had created controversy a few years ago, were sold in France in 2023. It was sold to 37.4 million patients.
4th place is occupied by Kardegic, an antithrombotic of which 26.7 million boxes were sold in France in 2023.
Ventolin, Spasfon, vitamin D…
Further down the rankings include Zymad, a vitamin D tablet (6th, 13.6 million boxes sold), Dafalgan codein (10th, 13.6 million boxes), Ventolin (12th, 12.8 million boxes), Methadone (13th, 12.3 million boxes), Amoxicillin (15th, 11.5 million boxes) or Spasfon (19th, 9.7 million boxes).
